Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
No peer-reviewed clinical studies, pharmacokinetic interaction data, or regulatory guidance exist on the combined use of AOD 9604 and retatrutide
For patients taking tirzepatide (Zepbound) who also use oral contraceptives, it's important to note that during dose escalation, exposure to oral contraceptives may be reduced
10
Data availability Access to NESDA data used in the present study can be obtained by submitting a research proposal
Additionally, the follow-up duration was generally 30,000 participants collectively 38,39,40
US$ 21.29
US$ 22.61
US$ 26.13
US$ 21.23
US$ 29.44
US$ 22.71
US$ 24.74
US$ 24.07
US$ 26.51
